- Home
- RVPH vs NMTC Comparison
RVPH vs NMTC Comparison
Compare RVPH & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- NMTC
- Stock Information
- Founded
- RVPH 2006
- NMTC 2009
- Country
- RVPH United States
- NMTC United States
- Employees
- RVPH N/A
- NMTC 17
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- NMTC Medical/Dental Instruments
- Sector
- RVPH Health Care
- NMTC Health Care
- Exchange
- RVPH Nasdaq
- NMTC Nasdaq
- Market Cap
- RVPH 32.8M
- NMTC 33.8M
- IPO Year
- RVPH N/A
- NMTC N/A
- Fundamental
- Price
- RVPH $0.37
- NMTC $0.70
- Analyst Decision
- RVPH Strong Buy
- NMTC Strong Buy
- Analyst Count
- RVPH 5
- NMTC 1
- Target Price
- RVPH $9.00
- NMTC $1.45
- AVG Volume (30 Days)
- RVPH 2.6M
- NMTC 173.4K
- Earning Date
- RVPH 08-13-2025
- NMTC 08-13-2025
- Dividend Yield
- RVPH N/A
- NMTC N/A
- EPS Growth
- RVPH N/A
- NMTC N/A
- EPS
- RVPH N/A
- NMTC N/A
- Revenue
- RVPH N/A
- NMTC $5,758,777.00
- Revenue This Year
- RVPH N/A
- NMTC $141.04
- Revenue Next Year
- RVPH N/A
- NMTC $38.86
- P/E Ratio
- RVPH N/A
- NMTC N/A
- Revenue Growth
- RVPH N/A
- NMTC 54.53
- 52 Week Low
- RVPH $0.30
- NMTC $0.40
- 52 Week High
- RVPH $4.28
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- RVPH 30.28
- NMTC 58.51
- Support Level
- RVPH $0.35
- NMTC $0.67
- Resistance Level
- RVPH $0.83
- NMTC $0.76
- Average True Range (ATR)
- RVPH 0.07
- NMTC 0.05
- MACD
- RVPH -0.04
- NMTC 0.01
- Stochastic Oscillator
- RVPH 11.32
- NMTC 67.76
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.